Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 37 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Gonadotropin-Releasing Hormone [Clear All Filters]
Unilateral renal agenesis as an early marker for genetic screening in Kallmann syndrome..
Hormones (Athens). 18(1), 103-105.
(2019). Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome..
Ultrasound Obstet Gynecol. 51(1), 126-133.
(2018). Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles..
Hum Reprod. 31(8), 1859-65.
(2016). Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial..
Hum Reprod. 31(5), 977-85.
(2016). Authors' reply..
BJOG. 122(4), 585-6.
(2015). Leptin increases luteinizing hormone secretion of fasting female rats..
Clin Exp Obstet Gynecol. 42(1), 18-21.
(2015). To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!.
Reprod Biomed Online. 31(1), 6-8.
(2015). Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study..
Gynecol Endocrinol. 30(11), 817-21.
(2014). Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET..
Arch Gynecol Obstet. 290(6), 1249-53.
(2014). Reply of the authors..
Fertil Steril. 101(1), e5-6.
(2014).
(2014). Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles..
Fertil Steril. 100(3), 742-7.
(2013). GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial..
Eur J Obstet Gynecol Reprod Biol. 166(1), 43-6.
(2013). GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients..
Hum Reprod. 28(9), 2511-21.
(2013). Is it possible to reduce the incidence of weekend oocyte retrievals in GnRH antagonist protocols?.
Reprod Biomed Online. 26(1), 50-8.
(2013). Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS..
Hum Reprod. 28(7), 1929-42.
(2013). Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles..
Hum Reprod Update. 19(5), 433-57.
(2013).
(2013). GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data..
Hum Reprod Update. 18(2), 228-9; author reply 229-30.
(2012). GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study..
Hum Reprod. 27(6), 1822-8.
(2012). Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study..
Reprod Biol Endocrinol. 10, 69.
(2012).
(2012). Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial..
Hum Reprod. 26(5), 1020-4.
(2011).
(2011).
(2011).